To unravel the molecular mechanisms underlying the selective perturbation of the recognition between CaM and RyR1 or RyR2 in arrhythmia-associated conditions, we focused on a CaM binding target region comprising 31 amino acids with a very similar sequence in the two RyRs (known as CaMBD2). The gene discussed is RYR1; the disease is cardiac arrhythmia.